Dallari R, Barozzi G, Pinelli G, Merighi V, Grandi P, Manzotti M, Tartoni P L
Divisione Medicina Interna, Ospedale Civile, Sassulo, Italia.
Respiration. 1994;61(1):8-13. doi: 10.1159/000196296.
We examined 166 patients with advanced chronic obstructive pulmonary disease (COPD) treated with long-term oxygen therapy (LTOT) in order to evaluate the prognostic factors of such patients. The mean observation period was 24 months (range 2-50 months) and the following variables were considered: age, forced expiratory volume in 1 s (FEV1), arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), hematocrit, right ventricular systolic pressure (RVSP; evaluated by Doppler echocardiography), number of hospitalizations in the 2 years prior to prescription of LTOT and body mass index. The overall survival rate was 78.3% at 24 months and 67.1% at 36 months. A univariate analysis identified three variables as significant predictors of survival: FEV1, PaO2 and RVSP. A multivariate analysis, using Cox's model, showed an independent predictive power for RVSP, age and FEV1. RVSP higher than 35 mm Hg, age greater than 70 years and FEV1 lower than 30% of the predicted value were associated with shortened survival. The importance of pulmonary hypertension as a predictor of death suggests that LTOT could be prescribed earlier for COPD patients with cor pulmonale, as oxygen has been shown to be the only effective therapy for improving the survival probability of these patients.
我们对166例接受长期氧疗(LTOT)的晚期慢性阻塞性肺疾病(COPD)患者进行了检查,以评估此类患者的预后因素。平均观察期为24个月(范围2 - 50个月),并考虑了以下变量:年龄、一秒用力呼气容积(FEV1)、动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、血细胞比容、右心室收缩压(RVSP;通过多普勒超声心动图评估)、LTOT处方前2年的住院次数和体重指数。24个月时的总生存率为78.3%,36个月时为67.1%。单因素分析确定了三个变量为生存的显著预测因素:FEV1、PaO2和RVSP。使用Cox模型的多因素分析显示,RVSP、年龄和FEV1具有独立的预测能力。RVSP高于35 mmHg、年龄大于70岁以及FEV1低于预测值的30%与生存期缩短相关。肺动脉高压作为死亡预测因素的重要性表明,对于患有肺心病的COPD患者,可以更早地开具LTOT处方,因为氧气已被证明是提高这些患者生存概率的唯一有效疗法。